REQUEST A DEMO
Total
USD $0.00
Search more companies

Bioforma S.A. Medicina Especializada (Colombia)

Main Activities: Ambulatory Health Care Services
Full name: Bioforma S.A. Medicina Especializada Profile Updated: January 23, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Spanish Download a sample report

Bioforma S.A. Medicina Especializada is an enterprise in Colombia, with the main office in Medellin. It operates in the Ambulatory Health Care Services industry. The company was established on December 13, 2000. 26 (2025) employees currently work for Bioforma S.A. Medicina Especializada. From the latest financial highlights, Bioforma S.A. Medicina Especializada reported a net sales revenue increase of 6.41% in 2025. Its’ total assets recorded a growth of 4.7%. The net profit margin of Bioforma S.A. Medicina Especializada increased by 2.83% in 2025.

Headquarters
Carrera 25 B 16 A Sur 211
Medellin; Antioquia;

Contact Details: Purchase the Bioforma S.A. Medicina Especializada report to view the information.

Website: http://bioforma.com.co

Basic Information
Total Employees:
Purchase the Bioforma S.A. Medicina Especializada report to view the information.
Registered Capital:
Purchase the Bioforma S.A. Medicina Especializada report to view the information.
Financial Auditors:
Purchase the Bioforma S.A. Medicina Especializada report to view the information.
Incorporation Date:
December 13, 2000
Key Executives
Purchase this report to view the information.
Legal Representative
Company Performance
Financial values in the chart are available after Bioforma S.A. Medicina Especializada report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
6.41%
Total Operating Revenue
6.41%
Operating Profit
43.61%
EBITDA
N/A
Net Profit/Loss for the Period
48.67%
Total Assets
4.7%
Total Equity
21.36%
Operating Profit Margin
4.96%
Net Profit Margin
2.83%
Return on Equity (ROE)
4.23%
Quick Ratio
0.07%
Cash Ratio
0.06%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?